Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Opalesque Search - enter search text below (options..)
Search term:  string and or
Case sensitive Search articles headlines only
Specify publication: 
All publication dates Today Yesterday Last 7 days Last 30 days Last 90 days Last 365 days
Publication dates from: search to: search  NB. All dates are dd/mm/yyyy.

HELPCENTER



Fri, 07 Jan 2011
Founders Q&A:What accounts for differences between trend-following programs by the same manager? The founder of Clarke Capital offers insights as to program design.
Futures Lab: Commodity rulemaking: Who will be affected by the proposals under consideration?
Insider Talk: 2011 and beyond: Opportunities and risks in futures markets. The Triton Capital team looks ahead.
Manager Profile A new CTA talks about his mostly shortterm strategies and how living in New Zealand influences his perspective.
Regulators: Matthew Kerfoot from law firm Dechert reviews possible regulatory changes related to commodity funds.
Top Ten Best performers since October 2005 from Managed Account Research Inc.
 Download as PDF 
Tue, 16 Nov 2010
Founders Q&A: Can drawdowns be kept down to less than 2%? Mesirow Financial's distinctive global macro strategy has done this. Co-portfolio manager Tom R Willis explains how.
Futures Lab: New handbook by Mark Melin offers comprehensive guidelines for managed futures investing, including ways to deal with risk.
Insider Talk: Veteran investor Richard Bornhoft picks managers for the mass affluent market. He explains his approach.
Regulators: A US mutual fund that invests in CTAs: What does the regulatory format mean in practice?
Practitioner View: Ira Kawaller rigorously disputes the idea that long-only commodities boost return
Index Tracker: Long commodities vs. managed futures: what the indexes say.
Top Ten: Largest CTA Firms.
 Download as PDF 
Fri, 22 Oct 2010

Founders Q&A: What if there's a bond bubble? 2100Xenon founder Jay Feuerstein provides insight on bond markets and fixed income futures trading.

Futures Lab: What does the expected second round of quantitative easing by the Federal Reserve mean?

Insider Talk : Emerging markets and managed futures: a report from MF Global suggests the combination has special characteristics.

Index Tracker: Gold, silver and commodity investments.

Regulators: Dodd-Frank rulemaking, palladium and platinum and increased enforcement actions by the CFTC.

Top Ten: Financials-only best performers in the past 12 months.

 Download as PDF 
Mon, 20 Sep 2010
Founders Q&A: John W. Henry & Co.' president discusses the experience of the past five years and explains why long-term trend following still works.
Futures Lab: A sample diversified portfolio of five CTAs.
Insider Talk: Current opportunities and portfolio construction in an environment of heightened uncertainty, from the founder of Integrated Energy Group and Integrated Capital Solutions .
Index Tracker: Crisis and correlations: the managed futures exception.
Regulators: Recent foreign exchange-related fraud cases: defendants include a pastor and an ex con.
Top Ten: A gold trading program leads these year-to-date winners.
 Download as PDF 
Wed, 18 Aug 2010
Founders Q&A: Agriculture specialist Brooks Brown discusses how agricultural markets work and explains his distinctive niche strategy Agriculture specialist Brooks Brown discusses how agricultural markets work and explains his distinctive niche strategy
Futures Lab: Learn about volatility forecasting and its uses from Laurence Wormald, head of research at SunGard APT.
Insider Talk:NuWave founder Troy Buckner sheds light on the recent experience in the grains market by using behavioral finance.
Manager profile:Auctos Capital manager Kevin Jamali on putting together a skill set, including a research team to develop diverse models.
Regulators:Convergence in wheat futures and cash market.
Top Ten: Agricultural and other non-financial CTAs.
 Download as PDF 

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for